Sedative Effects in Obstructive Sleep Apnea
Withdrawn prior to enrolment
Phase of Trial: Phase II/III
Latest Information Update: 22 Jun 2015
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- 31 May 2013 Planned end date changed from 1 Aug 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov.
- 31 May 2013 Planned initiation date changed from 1 Jan 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 03 Jan 2013 New trial record